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JCB: ARTICLE

A conserved CaM- and radial spoke–associated
complex mediates regulation of ﬂagellar
dynein activity
Erin E. Dymek and Elizabeth F. Smith

THE JOURNAL OF CELL BIOLOGY

Department of Biological Sciences, Dartmouth College, Hanover, NH 03755

F

or virtually all cilia and eukaryotic ﬂagella, the
second messengers calcium and cyclic adenosine
monophosphate are implicated in modulating dyneindriven microtubule sliding to regulate beating. Calmodulin
(CaM) localizes to the axoneme and is a key calcium
sensor involved in regulating motility. Using immunoprecipitation and mass spectrometry, we identify members
of a CaM-containing complex that are involved in
regulating dynein activity. This complex includes ﬂagellarassociated protein 91 (FAP91), which shares considerable

sequence similarity to AAT-1, a protein originally identiﬁed in testis as an A-kinase anchor protein (AKAP)–
binding protein. FAP91 directly interacts with radial spoke
protein 3 (an AKAP), which is located at the base of the
spoke. In a microtubule sliding assay, the addition of antibodies generated against FAP91 to mutant axonemes
with reduced dynein activity restores dynein activity to
wild-type levels. These combined results indicate that the
CaM- and spoke-associated complex mediates regulatory
signals between the radial spokes and dynein arms.

Introduction
For eukaryotic cells that use cilia and flagella for motile functions, motility is commonly modulated in response to extracellular cues; this modulation may include changes in waveform
(Brokaw et al., 1974; Brokaw, 1979; Bessen et al., 1980; Kamiya
and Witman, 1984), beat frequency (Verdugo, 1980), or direction of the effective stroke (Naitoh and Kaneko, 1972; Izumi
and Miki-Noumura, 1985). Despite the diversity of responses
between cell types, changes in motility are often preceded and
mediated by changes in the intraflagellar concentrations of the
second messengers calcium and cAMP. Ciliary and flagellar
beating results from the spatial regulation of dynein activity
along the axonemal microtubules (Satir, 1985). Our goal is to
understand how changes in intraflagellar calcium concentrations are converted to changes in dynein-driven microtubule
sliding to modulate motility.
Substantial evidence from our laboratory and others indicates that the central apparatus and radial spokes form a signal
transduction pathway that modulates ciliary and flagellar beating in response to second messengers (for reviews see Porter and
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Sale, 2000; Smith and Yang, 2004). Using both functional and
structural approaches, our previous studies demonstrated that
calcium control of motility involves the regulation of dyneindriven microtubule sliding and that CaM is a key axonemal
calcium sensor (Smith, 2002a,b; Wargo and Smith, 2003;
Wargo et al., 2004). Based on these results, we postulate that
the calcium sensor regulates the activity of specific dynein subforms and/or dynein arms attached to specific subsets of doublet microtubules, thus modulating the size and shape of ciliary/
flagellar bends.
Understanding how CaM might regulate dynein activity to
modulate ciliary motility requires the localization of CaM within
the axoneme as well as the identification of CaM binding
partners. Yang et al. (2001) have reported that a fraction but not
all of the axonemal CaM associates with the radial spokes in
Chlamydomonas reinhardtii. We have identified and characterized additional CaM-binding proteins in C. reinhardtii flagella
using an immunoprecipitation approach. We developed antibodies against a peptide antigen unique to the C terminus of
C. reinhardtii CaM and used these antibodies to precipitate CaM
from extracted axonemal proteins. We previously reported that
eight polypeptides precipitate with CaM and that these polypeptides form at least two different protein complexes (Wargo et al.,
2005). One complex is comprised of five polypeptides in addition to CaM and is associated with the C1 microtubule of the
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axonemal central apparatus (Wargo et al., 2005). Here, we report
the identities and localization of three polypeptides comprising
the second CaM-containing complex and provide data supporting the hypothesis that this complex plays an important role in
modulating the activity of specific subsets of dynein arms.

Results
CaM immunoprecipitation and peptide
identiﬁcation

To identify CaM-containing complexes within the axoneme,
we used anti-CaM antibodies in immunoprecipitation experiments (Wargo et al., 2005). Using extracts isolated from mutant
axonemes lacking the radial spokes (pf14), our anti-CaM antibodies precipitated a total of eight polypeptides in addition to
CaM (Fig. 1; see Fig. 4 a in Wargo et al., 2005). Five polypeptides form a complex that includes PF6 and localizes to the
C1a projection of the central apparatus (Wargo et al., 2005).
However, the three additional polypeptides that are precipitated
(designated CaM-IP2, -IP3, and -IP4; Fig. 1) are present in all
central apparatus–defective mutants, including pf6. Therefore,
these three polypeptides are not components of the radial spokes
or central apparatus. These three polypeptides are also precipitated from extracts isolated from mutant axonemes lacking the
outer dynein arms and inner arm I1 (pf28pf30; Fig. 1) as well as
the inner arm–defective strains mia1 and mia2 (not depicted),

Figure 1. Silver-stained gels of immunoprecipitation experiments using antiCaM antibodies and extracts isolated from wild-type, radial spokeless (pf14),
and central pairless (pf18) axonemes as well as axonemes lacking both the
outer dynein arms and inner arm isoform I1 (pf28pf30). The precipitates
were resolved on either a 7% (top) or 12% (bottom) acrylamide gel. Central
apparatus proteins are indicated by dots; spoke proteins are indicated by
triangles. CaM-IP2, -IP3, and -IP4 are indicated by asterisks. The darkly
stained bands are the heavy (HC) and light (LC) chains from the antibodies.
CaM-IP2, -IP3, and -IP4 are precipitated from all of the mutant extracts tested,
indicating that these polypeptides are not components of the radial spokes,
central apparatus, outer dynein arms, or inner dynein arm I1.
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indicating that they do not localize to these dynein subforms.
All three polypeptides are also precipitated from the move
backward–only strains mbo1 and mbo2 (unpublished data),
indicating that the assembly of these polypeptides is unaffected
in these mutant strains.
To determine the identities of CaM-IP2, -IP3, and -IP4,
these polypeptides were excised from gels and analyzed by mass
spectrometry (see Materials and methods; data summarized in
Table I). The identity of CaM-IP2 was determined from four
peptide sequences. Based on searches of the C. reinhardtii
genome database (version 3.0; http://genome.jgi-psf.org/Chlre3/
Chlre3.home.html), the CaM-IP2 gene is located on the same
contig as Zsp1; therefore, the CaM-IP2 gene is most likely on
linkage group VII. In searches of the C. reinhardtii proteome
database, CaM-IP2 is flagellar-associated protein 91 (FAP91;
Pazour et al., 2005). BLAST searches reveal that CaM-IP2
(FAP91) is most similar to the human homologue of AAT-1
(C3orf15; GenBank/EMBL/DDBJ accession no. AAH35238;
E value of E = 7e-49). AAT-1 was originally identified as a
testis-specific protein in mice that forms a quaternary complex
with AMY-1 (a c-myc–binding protein), an A-kinase anchoring
protein (AKAP), and two regulatory subunits of PKA (cAMPdependent protein kinase; Yukitake et al., 2002). More recently,
a total of seven alternatively spliced isoforms of AAT-1 have
been identified, and some of these isoforms are expressed in a variety of human tissues (Matsuda et al., 2005). The largest isoform
of AAT-1, AAT-1L, is an 90-kD protein. The testis-specific
isoform AAT-1α is reported to contain only the C-terminal 98
amino acids of AAT-1L.
CaM-IP2 is 32% identical and 49% similar to AAT-1 over
a stretch of 423 amino acids at the N terminus (Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb.200703107/DC1).
Sequence similarity with AAT-1 may extend beyond the N terminus of the protein, but the C-terminal half of the CAM-IP2
sequence is not represented in the C. reinhardtii genome.
We have tried to complete the CaM-IP2 coding sequence using
a variety of approaches, including 5′ and 3′ rapid amplification
of cDNA ends, obtaining small genomic fragments of CaM-IP2
for sequencing, and optimizing our sequencing reactions for
GC-rich sequences. We have confirmed the predicted amino
acid sequence for the N-terminal one third of the protein but
were unsuccessful in obtaining the complete coding sequence.
As judged by SDS-PAGE, the apparent molecular mass of
CaM-IP2 is 183 kD, which is almost double that of AAT-1L.
However, Northern blots of RNA isolated from wild-type cells
indicate that the CaM-IP2 transcript is 4.4 kb (Fig. S2). Based
on our experience comparing C. reinhardtii genomic and coding sequences, the true molecular weight of this protein is most
likely no greater than 120 kD.
The identity of CaM-IP3 was determined from the amino
acid sequence of five peptides. Based on database searches, CaMIP3 is located on linkage group III and corresponds to FAP61.
Using corresponding cDNA sequences in the C. reinhardtii
expressed sequence tag (EST) database and RT-PCR, we determined that the CaM-IP3 gene encodes a 1,115–amino acid
protein that contains a predicted NADH dehydrogenase domain.
This domain is found in both class I and II oxidoreductases as well

Table I. Proteins precipitated with anti-CaM antibodies
Name
CaM-IP2

Predicted
molecular mass

Apparent
molecular mass

pI

Similarities

Flagellar
proteome

Linkage
group

ND

183 kD

ND

AAT-1, AKAP-binding
protein
pyridine-disulﬁde
oxidoreductase domain
WD repeats

FAP91

VII

FAP61

III

FAP251

III

CaM-IP3

118 kD

140 kD

4.8

CaM-IP4

97 kD

100 kD

7.4

as NADH oxidases and peroxidases. The domain includes a small
NADH-binding domain within a flavin adenine dinucleotide–
binding domain and, thus, is thought to be involved in energy
conversion. Searches of sequence databases reveal that the predicted human protein C20orf26 is most similar to CaM-IP3
(E value of E = 6.8e-56), sharing 25% identity and 43% amino
acid similarity along the entire length of the protein. The predicted molecular mass of CaM-IP3 is 118 kD, although the
protein has an apparent molecular mass of 140 kD as judged
by SDS-PAGE. The acidic isoelectric point of CaM-IP3 (4.76)
may partially account for this discrepancy.
The identity of CaM-IP4 was determined from the amino
acid sequence of five peptides. Based on database searches,
CaM-IP4 is also located on linkage group III and corresponds to
FAP251. CaM-IP4 contains seven WD-40 repeats that comprise much of the N terminus of the protein. WD-40 repeats
form propeller-like structures that serve as an interface for
protein–protein interactions (Neer et al., 1994). In searches of
sequence databases, a protein predicted from the Leishmania
database (GenBank/EMBL/DDBJ accession no. XM811714;
E value of E = 9e-53) is most similar to CaM-IP4 with 29%
amino acid identity and 43% similarity along the entire length
of this protein. CaM-IP4 is also 24% similar and 39% identical
to a protein predicted from the human genome sequence (GenBank/EMBL/DDBJ accession no. BC036233; E value of E =
6e-37). All of these polypeptides show similarity to microtubule-associated protein–like 5 from echinoderms. In addition
to the WD-40 repeats, each of these proteins has a putative EFhand domain at the C terminus. Although a motifs search does
not predict an EF hand at the C terminus of CaM-IP4, the InterProScan algorithm provided by the European Molecular Biology Laboratory predicts an EF hand–like domain.

specifically precipitated CaM-IP2 as well as -IP3 and -IP4 from
extracts isolated from radial spokeless axonemes (Fig. 2 B,
middle lane). For extracts isolated from wild-type and pf18
axonemes, additional polypeptides are precipitated by the
CaM-IP2 antibodies that are not precipitated from extracts of the
spokeless mutant pf14. Based on the molecular weights of these
polypeptides (Yang et al., 2001) as well as their absence from
precipitates of pf14 axonemal extracts, we suspected that these
polypeptides were radial spoke components. Corresponding
Western blots using antibodies generated against radial spoke
protein 2 (RSP2) and RSP3 confirm that RSPs are precipitated
by the CaM-IP2 antibodies. The simplest interpretation of these

CaM-IP2, -IP3, and -IP4 form a
single complex

Based on CaM immunoprecipitation, it is possible that CaMIP2, -IP3, and -IP4 bind CaM individually, in subsets, or together
to form a single complex. To differentiate among these possibilities, we developed polyclonal antibodies in rabbits against
either bacterially expressed protein fragments or synthetic peptides for each of CaM-IP2, -IP3, and -IP4 (see Materials and
methods). CaM-IP4 proved to be nonantigenic. However, we
were successful in obtaining antibodies that specifically recognize either CaM-IP2 or CaM-IP3 on Western blots (Fig. 2 A).
We then used these antibodies in immunoprecipitation
experiments. Antibodies generated against CaM-IP3 failed to
precipitate CaM-IP3. On the other hand, the CaM-IP2 antibody

Figure 2. CaM-IP2, -IP3, and -IP4 form a single complex that is associated with the radial spokes. (A) Western blots of axonemes (8 μg per lane)
probed with antibodies generated against CaM-IP2 and -IP3. Both polypeptides are present in all axonemes in approximately equal amounts. (B) Silverstained gel (top) and corresponding Western blots (middle and bottom) of
immunoprecipitation experiments using anti–CaM-IP2 antibodies and wildtype, radial spokeless (pf14), and central pairless (pf18) axonemal extracts.
CaM-IP2 antibodies precipitate the CaM-IP2, -IP3, and -IP4 complex
(asterisks) as well as RSPs (triangles). Blots were probed with antibodies
generated against CaM-IP2, -IP3, RSP2, or RSP3. These results indicate
that CaM-IP2, -IP3, and -IP4 form a single complex that is associated with
the radial spokes.
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reveal that CaM-IP2 and -IP3 cosediment with the radial
spokes. For axonemal extracts isolated from flagella that lack
the spoke heads (pf17), the polypeptides comprising the spoke
stalks cosediment at 15S (Yang et al., 2001). Western blots
of corresponding gradient fractions from pf17 extracts reveal
that CaM-IP2 and -IP3 also cosediment with the radial spoke
stalks (Fig. 3 B). For axonemal extracts isolated from flagella
that completely lack the radial spokes (pf14), CaM-IP2 and -IP3
cosediment as a smaller complex at 11S (Fig. 3 C). Although
we do not have antibodies that recognize CaM-IP4, immunoprecipitation experiments using sucrose gradient fractions confirm that CaM-IP4 also cosediments with CaM-IP2, -IP3, and
-IP4 (Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200703107/DC1). These results support the hypothesis that
CaM, CaM-IP2, -IP3, and -IP4 form a single complex that is
associated with the spoke stalk.
As noted in our CaM-IP2 sequence analysis, CaM-IP2
is most similar to AAT-1, which is thought to form a quaternary complex with an AKAP-binding protein. Based on previous reports that RSP3 is an AKAP (Gaillard et al., 2001), that
RSP3 is located at the base of the radial spoke stalk (Diener
et al., 1993), and our results that CaM-IP2 cosediments with the
spoke stalk (this study), we hypothesized that CaM-IP2 binds
to RSP3. To test this hypothesis, we used a gel overlay assay.
Bacterially expressed proteins (CaM-IP2, CaM-IP3, and RSP3)
were resolved by SDS-PAGE and transferred to nitrocellulose
membrane. The membrane was then incubated with bacterially
expressed C. reinhardtii RSP3, and the overlain protein was detected by immunoblotting. As shown in Fig. 3 D, RSP3 binds
only to CaM-IP2. These combined results indicate that CaMIP2, -IP3, and -IP4 are associated with the radial spoke stalk via
interactions between CaM-IP2 and RSP3.
CaM binding is calcium sensitive
Figure 3. CaM-IP2 is associated with RSP3. Western blots of extracts isolated from wild-type (A), spoke headless (B; pf17), and spokeless (C; pf14)
axonemes fractionated on sucrose gradients. Blots were probed with antibodies generated against CaM-IP2, -IP3, RSP2, RSP3, or CaM. In extracts
isolated from both wild-type or pf17 axonemes, CaM-IP2 and -IP3 cosediment with spoke stalk components. In extracts isolated from both pf17 and
pf14 mutant axonemes, the sedimentation value for the CaM-IP2 complex
is considerably lower than that in wild type. (D) Gel overlay of expressed
RSP3. Bacterial extracts expressing fragments of CaM-IP2 (37 kD), -IP3
(32 kD), -IP4 (60 kD), and RSP3-GST (110 kD) were resolved on polyacrylamide gels and either transferred to nitrocellulose (left) or stained with
Coomassie blue (right). The membrane (left) was incubated with expressed
RSP3 and probed with antibodies generated against RSP3. These results
indicate that RSP3 binds to CaM-IP2.

results is that CaM and CaM-IP2, -IP3, and -IP4 form a single
complex that is associated with the radial spokes.
CaM-IP2 binds to RSP3

To provide further evidence that the CaM-IP2, -IP3, and -IP4
complex is associated with the radial spokes, we investigated
whether this complex cosediments with the radial spokes
using sucrose density gradient centrifugation (Fig. 3). For axonemal extracts isolated from wild-type flagella, the polypeptides comprising the radial spokes cosediment at 20S (Yang
et al., 2001). Western blots of corresponding gradient fractions
518
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The association of CaM with specific proteins is regulated by
the calcium-binding state of CaM. All immunoprecipitation
experiments were performed using low calcium conditions.
Therefore, the eight polypeptides we precipitated do not require calcium to form protein complexes with CaM. To investigate whether CaM binding of these polypeptides is calcium
sensitive, we first immunoprecipitated CaM from pf14 axonemal extracts under low calcium conditions; the protein A
beads were then washed using high calcium buffer (see Materials
and methods). CaM remained associated with the beads, whereas
CaM-IP2, -IP3, and -IP4 were selectively extracted in the
presence of high calcium (Fig. 4 A). These results demonstrate
that the binding of CaM-IP2, -IP3, and -IP4 to CaM is calcium
sensitive. We also performed immunoprecipitation experiments using the CaM-IP2 antibody under high calcium conditions. All three members of the complex are precipitated by
the CaM-IP2 antibody in extracts from spokeless axonemes,
indicating that the complex does not dissociate under high
calcium conditions (Fig. 4 B). In addition, the CaM-IP2 antibodies precipitate the spokes from axonemal extracts isolated
from either wild-type or central pairless axonemes, indicating
that the complex does not dissociate from the spokes under
high calcium conditions (Fig. 4 B).

complex from axonemal extracts isolated from DRC mutants
(pf2 and pf3) using either our anti-CaM or anti–CaM-IP2 antibodies. The anti-CaM antibodies precipitate substantially less
CaM-IP2, -IP3, and -IP4 from pf2 and pf3 axonemal extracts
compared with that precipitated from wild-type extracts even
though axonemes isolated from these mutants appear to have
wild-type levels of CaM as judged by Western blotting (Fig. 5).
These results suggest that the assembly of CaM-IP2, -IP3, and
-IP4 is defective in DRC mutants. However, when we precipitate
the complex using our anti–CaM-IP2 antibodies, the precipitates from pf2 and pf3 are indistinguishable from that of wild
type (Fig. 5). These results indicate that CaM-IP2, -IP3, and
-IP4 assemble normally in DRC mutants but that their association with CaM is disrupted.
Anti–CaM-IP2 antibodies restore dynein
activity to mutant axonemes

Figure 4. Binding of CaM-IP2, -IP3, and -IP4 to CaM is calcium sensitive.
(A) Silver-stained gel of CaM immunoprecipitation from radial spokeless
axonemal extracts (pf14) followed by treatment with CaCl2 (top). After precipitation (CaM-IP), the protein A beads were washed twice with 2 mM
CaCl2 (Ca2+1 and Ca2+2), and the resulting extract was loaded onto the
gel. Proteins remaining (lane R) associated with the beads after the CaCl2
wash were eluted with sample buffer. CaM-IP2, -IP3, and -IP4 (asterisks)
are extracted from the beads. In contrast, the central pair proteins (dots)
are not extracted with CaCl2. Western blots using anti-CaM antibodies
(bottom) reveal that CaCl2 extracts very little CaM from the beads. These
results indicate that binding of CaM-IP2, -IP3, and -IP4 to CaM is calcium
sensitive. (B) Silver-stained gel of immunoprecipitation experiments performed in 1 mM CaCl2 using anti–CaM-IP2 antibodies and wild-type,
spokeless (pf14), and central pairless (pf18) axonemal extracts. The CaMIP2 antibodies precipitate the CaM-IP2, -IP3, and -IP4 complex (asterisks)
and spokes (triangles), indicating that they do not dissociate from each
other or the spokes in high calcium buffer conditions.

The association of CaM-IP2, -IP3, and -IP4
with CaM is altered in DRC mutants

Our data are consistent with the localization of a CaM-containing
complex at the base of the spokes. Previous studies have indicated that the components of the dynein regulatory complex
(DRC) localize to the doublet microtubules near the spokes
(Piperno et al., 1992; Gardner et al., 1994; Nicastro et al., 2006).
Therefore, we hypothesized that the CaM-IP2, -IP3, and -IP4
complex may be disrupted in mutants lacking subsets of DRC
components. To investigate this possibility, we precipitated the

Localization of the CaM-IP2, -IP3, and -IP4 complex at the
base of the radial spokes, potentially near DRC components,
suggested a possible role in modulating dynein-driven microtubule sliding. Based on this localization, we hypothesized
that regulation of dynein activity by this complex would occur
downstream of regulatory signals derived from the radial spokes
or central apparatus. To test this hypothesis, we conducted the
microtubule sliding assay in the presence of the anti–CaM-IP2
antibody. We initially tested whether the antibodies possessed
any function-blocking activity using wild-type axonemes and
a microtubule sliding assay (see Materials and methods). The
anti–CaM-IP2 antibodies had no effect on microtubule sliding
velocity (Fig. 6 A).
We then examined dynein activity in mutant axonemes.
The first mutant tested was the central pairless strain pf18;
axonemes from this mutant have reduced dynein activity compared with wild-type (Smith, 2002b). To our surprise, the anti–
CaM-IP2 antibody significantly increases microtubule sliding
velocity (P < 0.001 by t test; Fig. 6 A). In addition, the increase
in velocity in central pairless axonemes is dependent on the
concentration of the antibody, with maximal effect at 0.2 μM
CaM-IP2 antibody (Fig. 6 B). Importantly, the increase in dynein activity is not observed upon the addition of anti–CaM-IP3
or anti-C1a32 antibodies (Wargo et al., 2005), further indicating
that the effect is specific for binding of the anti–CaM-IP2 antibody. Based on these results and the hypothesis that the complex affects dynein activity downstream of regulatory cues from
the radial spokes, we predicted that addition of our antibodies to
radial spokeless axonemes would also increase dynein activity.
Indeed, addition of the CaM-IP2 antibodies to radial spokeless
axonemes (pf14) significantly increases dynein activity (P <
0.001 by t test; Fig. 6 D). The simplest interpretation of these
results is that the CaM-IP2, -IP3, and -IP4 complex is involved
in modulating the activity of the dynein arms.
To determine whether specific subforms of axonemal
dynein are the targets for modulation by this complex, we repeated the sliding microtubule experiments using mutants that
lack specific dynein subforms. The CaM-IP2 antibodies have
no effect on the sliding velocities of a mutant lacking the outer
dynein arms (pf28; Fig. 6 C). Double mutants lacking both the
REGULATION OF DYNEIN ACTIVITY • DYMEK AND SMITH
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Figure 5. Association of the CaM-IP2 complex with CaM is disrupted in DRC mutants. (A) Silver-stained gel of immunoprecipitates
using either anti-CaM or anti–CaM-IP2 antibodies and axonemal
extracts isolated from wild-type (wt), spokeless (pf14), or DRC mutant (pf2 and pf3) axonemes. Compared with wild-type and pf14
precipitates, the CaM-IP2 complex is substantially reduced in precipitates of pf2 and pf3 extracts using the anti-CaM antibodies.
However, immunoprecipitation using the anti–CaM-IP2 antibodies
indicates that relatively equal amounts of CaM-IP2, -IP3, and -IP4
(asterisks) are precipitated in wild-type, pf2, and pf3 axonemes.
(B) Western blot of isolated axonemes using anti-CaM antibodies.
The pf2 and pf3 mutant axonemes have wild-type levels of CaM.
These combined results indicate that association of the CaM-IP2
complex with CaM is disrupted in DRC mutants.

central apparatus and outer dynein arms (pf18pf28) or radial
spokes and outer dynein arms (pf14pf28) have shorter length
flagella than wild type, and many of the isolated axonemes fail
to undergo microtubule sliding in this assay. However, for those
pf18pf28 axonemes in which microtubule sliding occurred,
velocities doubled upon addition of the CaM-IP2 antibodies
(Fig. 6 C). These velocities are significantly lower than those of
pf28 (P < 0.001 by t test). The CaM-IP2 antibodies had no effect on the sliding velocity of pf14pf28 axonemes. These results
indicate that the outer dynein arms may be one of but not the
exclusive targets of regulation by the CaM complex. Therefore,
we also compared dynein activity in double mutants lacking
various inner dynein arm subforms.
Addition of the CaM-IP2 antibody restored dynein activity in mutant axonemes lacking the central apparatus and the
I2 inner arms (pf18ida4; Fig. 6 D; Piperno et al., 1992), which
are also known as fast protein liquid chromatography fractions
a, c, and d (Kagami and Kamiya, 1992; Porter et al., 1992).
The CaM-IP2 antibodies increased sliding velocities of pf18ida4
axonemes to levels not significantly different (P > 0.22 by t test)
from those of pf18 axonemes incubated with CaM-IP2 antibody.
These results suggest that the I2 inner arms are not the targets of
regulation by this complex.
The pf30 and ida1 mutants lack the inner arm I1 or fraction f
heavy chains (Piperno et al., 1990; Kagami and Kamiya, 1992;
Porter et al., 1992). Addition of the CaM-IP2 antibodies to
axonemes isolated from the pf14pf30 mutant that lack the spokes
and the I1 inner dynein arm failed to increase dynein activity
(Fig. 6 D). These results indicate that I1 is a target for regulation
by this complex. We previously reported that double mutants
lacking I1 and the central apparatus (pf18ida1) have microtubule sliding velocities that are significantly greater than those
of pf18 axonemes (P < 0.001 by t test; Smith, 2002b). The loss of
I1 from central pairless mutants partially relieves the inhibition
of microtubule sliding in central apparatus–defective mutants.
However, sliding velocities of pf18ida1 are also significantly
lower than those of pf18 axonemes exposed to the CaM-IP2 antibodies (P < 0.001 by t test; Fig. 6 D). Addition of the CaM-IP2
520
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antibodies to pf18ida1 mutant axonemes failed to increase dynein
activity to wild-type levels. These combined results support the
hypothesis that the CaM-IP2, -IP3, and -IP4 complex plays a
role in modulating the activity of inner dynein arm I1.
Previous studies have indicated that reduced sliding velocities in central pairless and radial spokeless mutants is correlated with the phosphorylation state of the IC138 intermediate
chain of the I1 inner dynein arm (Habermacher and Sale, 1996,
1997; King and Dutcher, 1997; Yang and Sale, 2000; Hendrickson
et al., 2004). Reducing the phosphorylation of IC138 using kinase inhibitors results in increased sliding velocities in these
mutants (Habermacher and Sale, 1997; Yang and Sale, 2000;
Smith, 2002b). Therefore, we hypothesized that addition of the
CaM-IP2 antibodies to mutant axonemes may result in reduced
IC138 phosphorylation and, therefore, increased dynein activity.
Using antibodies generated against IC138, we performed Western blots of isolated axonemes in the presence or absence of
CaM-IP2 antibodies (Fig. 7). Phosphorylated forms of IC138
have been detected on Western blots of radial spoke– and central apparatus–defective axonemes as slower migrating species
that are not present when samples are treated with phosphatase
(Hendrickson et al., 2004). We do not detect any decrease in the
overall phosphorylation state of IC138 in either radial spokeless
(pf14) or central pairless (pf18) axonemes upon the addition
of anti–CaM-IP2 antibodies. These results suggest that the
CaM-IP2 antibodies do not increase dynein activity by affecting
the phosphorylation state of I1 IC138. Alternatively, the phosphorylation state of specific residues may be affected that cannot be detected by Western blotting.

Discussion
Our previous studies demonstrated that calcium control of
motility involves the regulation of dynein-driven microtubule
sliding and that CaM is a key axonemal calcium sensor (Smith,
2002a,b; Wargo et al., 2004). Using a combination of biochemical and functional approaches, we have identified a protein complex that exhibits calcium-sensitive CaM binding, localizes to

Figure 6. CaM-IP2 modulates dynein-driven
microtubule sliding. (A) Microtubule sliding velocities of wild-type and pf18 axonemes. The CaMIP2 (IP2) antibodies have no effect on the sliding
velocity of wild-type axonemes. In contrast, sliding velocities of pf18 axonemes increase upon
addition of the CaM-IP2 antibody. This increase
is not observed in the presence of C1a-32 (C1a;
Wargo et al., 2005) or CaM-IP3 (IP3) antibodies.
(B) Microtubule sliding velocities of pf18 axonemes incubated with varying concentrations
of CaM-IP2 antibody. The increase in dynein
activity is dose dependent, with a maximal increase in velocity at 0.2 μM CaM-IP2 antibody.
(C) Microtubule sliding velocities of mutants lacking the outer dynein arms (pf28), outer dynein
arms and the central apparatus (pf18pf28), and
outer dynein arms and spokes (pf14pf28) in
the presence (IP2; patterned bars) and absence
(black bars) of the CaM-IP2 antibody. (D) Sliding velocities of a mutant lacking the central
pair and I2 inner arm heavy chains (pf18ida4)
increase upon the addition of anti–CaM-IP2
antibodies. Velocities of a mutant lacking the
central apparatus and the I1 inner dynein arm
(pf18ida1) are signiﬁcantly higher than velocities of pf18 (P < 0.001 by t test). However, sliding velocities of pf18ida1 axonemes incubated
with CaM-IP2 antibodies are signiﬁcantly lower
than those of pf18 incubated with CaM-IP2 antibodies (P < 0.001 by t test). Sliding velocities of
a radial spokeless mutant (pf14) increase upon
the addition of anti–CaM-IP2 antibodies (IP2).
However, the addition of CaM-IP2 antibodies to
axonemes that lack the radial spokes and inner
dynein arm I1 (pf14pf30) have no effect on sliding velocity. All bars represent the mean of >70
measurements ± SEM (error bars) from three or
more independent experiments. (E) Summary of
microtubule sliding experiments. The CaM-IP2,
-IP3, and -IP4 complex (purple) is localized to the
base of the spoke (blue).

the base of the radial spokes, and plays an important role in
modulating dynein-driven microtubule sliding. This discovery
represents an important step toward defining a molecular mechanism for control of ciliary and flagellar motility.
The identities of CaM-IP2, -IP3, and -IP4
suggest a role in regulating motility

Three polypeptides precipitated by anti-CaM antibodies form
a distinct complex with CaM and were tentatively named
CaM-IP2, -IP3, and -IP4. Based on the amino acid identities of
these polypeptides and searches of the C. reinhardtii flagellar
proteome, we determined that CaM-IP2, CaM-IP3, and CaMIP4 correspond to FAP91, FAP61, and FAP251, respectively
(Pazour et al., 2005). Potential mammalian homologues for each
of these proteins were found in searches of sequence databases,
indicating that this complex is not unique to C. reinhardtii. Most
notably, CaM-IP2 (FAP91) is most similar to AAT-1, a protein
originally identified as a testis-specific protein that interacts

with AMY-1 (a c-myc–binding protein), an AKAP, and two
regulatory (RII) subunits of PKA (cAMP-dependent protein
kinase; Yukitake et al., 2002). Based on gel overlay assays, we
have shown that CaM-IP2 binds to an AKAP (RSP3; Gaillard
et al., 2001); however, none of the members of this complex appear to be AMY-1 or RII homologues. AAT-1α, a small splice
variant of AAT-1, has been localized to mature sperm and appears concentrated in the sperm midpiece region (Matsuda et al.,
2005). Matsuda et al. (2005) suggest that AAT-1α may be associated with mitochondria, but the precise localization of AAT-1α
within sperm has not yet been determined.
In addition to AAT-1α, Matsuda et al. (2005) report the
presence of several splice variants of AAT-1 expressed in various tissues, some of which have cells that possess cilia/flagella
and some of which do not. The authors propose that AAT-1
may participate in additional cellular functions as well as sperm
development. Northern blots of RNA isolated from C. reinhardtii
cells before and after deflagellation reveal that C. reinhardtii
REGULATION OF DYNEIN ACTIVITY • DYMEK AND SMITH
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Figure 7. Western blots of isolated axonemes
(10 𝛍g/lane) probed with antibodies generated against the I1 intermediate chain IC138.
Intermediate chain IC138, left. As indicated,
some axoneme samples were treated with either anti–CaM-IP2 or anti–C1a-32 antibodies
(C1a; Wargo et al., 2005) in the presence or
absence of calf intestinal alkaline phosphatase
(CIP). In the absence of calf intestinal alkaline
phosphatase treatment, IC138 appears hyperphosphorylated in both central pairless (pf18)
and spokeless (pf14) axonemes compared with
wild type. No observable difference in phosphorylation is detected after the addition of
CaM-IP2 antibodies. The 120–150-kD molecular
mass range of Coomassie blue–stained gels of
the same samples are shown as a loading control (right).

possesses a single CaM-IP2 transcript that increases in abundance after deflagellation. Therefore, in C. reinhardtii, CaM-IP2
is most likely present in a single isoform that primarily localizes to the flagellum. The presence of multiple splice variants
of axonemal proteins in mammals, which are not observed for
their C. reinhardtii homologues, has been previously reported
(Zhang et al., 2002).
The fact that CaM-IP2 is associated with both CaM and
an AKAP (RSP3) raises the intriguing possibility that this complex may play a role in integrating the calcium- and cAMPmediated signaling pathways to produce particular changes in
motility. Yukitake et al. (2002) found that mammalian AAT-1α
weakly stimulated the activity of PKA and that AAT-1α itself
was phosphorylated by PKA in vivo and in vitro. Although bona
fide PKA homologues are not represented in the C. reinhardtii
flagellar proteome, several AKAPS as well as proteins with
domains similar to the PKA RII subunit have been identified
(Gaillard et al., 2001; Yang et al., 2006). In addition, pharmacological and functional studies have implicated a role for PKA
in modulating motility (Howard et al., 1994; Habermacher and
Sale, 1995, 1997; Gaillard et al., 2006). We are currently investigating whether CaM-IP2 is posttranslationally modified
in vivo in C. reinhardtii.
The presence of an NADH dehydrogenase domain in
CaM-IP3 (FAP61) is suggestive of a role for this protein in energy
conversion. This domain is found in oxidoreductases as well as in
NADH oxidases and peroxidases. Wakabayashi and King (2006)
have recently shown that in C. reinhardtii, motility changes that
occur in response to light are altered by oxidative/reductive stress
and that this effect is mediated by the redox poise of the outer
dynein arms (Wakabayashi and King, 2006). Given that motility
changes in response to light are generally preceded by changes
in intraflagellar calcium, that CaM-IP3 is part of a complex that
contains CaM, and that CaM-IP3 possesses an NADH dehydrogenase domain, one possibility is that CaM-IP3 plays a role in
mediating calcium-induced changes in the flagellar redox state
that affect the activity of the outer dynein arms.
CaM-IP2, -IP3, and -IP4 form a CaM- and
spoke-associated complex

The conclusion that the CaM-IP2, -IP3, and -IP4 complex is
associated with and localizes to the base of the radial spokes is
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based on the following observations. First, antibodies raised
against CaM-IP2 precipitate all members of this complex as
well as the radial spokes. Second, the complex cosediments
with the radial spokes and spoke stalks on sucrose gradients
of axonemal extracts. Finally, gel overlay assays using recombinant RSP3 reveal that RSP3 binds specifically to CaM-IP2.
Previous studies have shown that mutations in RSP3 (pf14) result in the failure of the entire radial spoke to assemble (Huang
et al., 1981) and that recombinant RSP3 binds to pf14 axonemes
(Diener et al., 1993). Therefore, RSP3 is predicted to localize
to the base of the spoke and serve as a point of stalk attachment
to the axonemal microtubule. Based on the clear association of
the CaM-IP2, -IP3, and -IP4 complex with both CaM and the
radial spokes, we propose to use the acronym CSC (CaM- and
spoke-associated complex) to refer to this complex.
Given that the CSC is associated with the radial spokes
in wild-type axonemal extracts, it may seem surprising that this
complex was not identified in analyses of the radial spoke proteome (Yang et al., 2006). However, two important factors indicate that this complex is not part of the spoke structures. First,
the pf14 mutation results in the complete failure of the spokes
to assemble; therefore, comparisons of polypeptides lacking in
this mutant with those present in wild-type axonemes have historically defined radial spoke components (Huang et al., 1981;
Piperno et al., 1981). Because we initially identified this complex in immunoprecipitation experiments using axonemal extracts isolated from pf14 axonemes, its presence in this mutant
would eliminate the possibility that it is part of the radial spoke
structure. Second, although candidate spots possibly corresponding to these proteins are visible on the two-dimensional gels of
isolated spokes by Yang et al. (2001), they are clearly present in
substoichiometric amounts relative to other spoke components.
Therefore, if these spots are in fact CSC components, it is possible that not every spoke is associated with a CSC. Given their
presence in spokeless mutants and the fact that they may be present in substoichiometric amounts relative to spoke proteins, the
CSC polypeptides do not appear to be components of the spoke
structures. Experiments are currently underway to define the precise stoichiometry of this complex to radial spokes as well as their
more precise localization within the axoneme.
Based on the apparent localization of the CSC to the
base of the spokes, the mutant phenotype for members of this

complex might predictably include defects in radial spoke
assembly. In fact, CaM-IP3 and -IP4 map to linkage group III
near the pf5 mutation, and the pf5 mutant is defective for radial
spoke assembly (Huang et al., 1981). We have sequenced the
genes encoding CaM-IP3 and -IP4 from genomic DNA isolated from the pf5 mutant and found no mutations in either gene
(unpublished data). In addition, we have screened several available insertional mutant libraries for mutations in the members of
this complex and found no candidate mutants. Finally, we have
made numerous attempts at knocking down expression levels
by RNA-mediated interference for both CaM-IP2 and -IP3 and
have not obtained a stable mutant with reduced transcript levels
for either gene. Therefore, the mutant phenotype for any member of this complex remains unknown.
The CSC regulates dynein-driven
microtubule sliding

Using a microtubule sliding assay, we have demonstrated that
the CSC plays a role in regulating dynein-driven microtubule
sliding. This conclusion is based on the observation that the addition of antibodies raised against CaM-IP2 specifically restores
dynein activity to axonemes that lack either the central apparatus
or the radial spokes. Importantly, the increase in dynein activity
is not observed upon the addition of antibodies raised against
CaM-IP3 or C1a32, and the CaM-IP2 antibody effect is saturable. Therefore, the increase in dynein activity is not caused by
particular buffer or rabbit serum components that may remain
after affinity purification; rather, the increase in dynein activity
is specific for binding of the anti–CaM-IP2 antibody.
The challenge now is to determine the mechanism by
which the CSC regulates dynein activity. One possibility is that
the CSC directly mediates regulatory signals from the radial
spokes to the dynein arms. A second possibility is that the CSC
mediates regulatory signals via the DRC. The DRC is comprised of seven polypeptides that were discovered through genetic and biochemical analyses of mutants that, when combined
with central apparatus or radial spoke defect mutations, restored
motility without restoring the missing structures (Huang et al.,
1982; Piperno et al., 1992). The polypeptides comprising the
DRC have been localized near the base of the spokes (Gardner
et al., 1994; Nicastro et al., 2006). However, little is know about
their identities or their function in regulating dynein (Rupp and
Porter, 2003).
In these experiments, we have discovered that the two
mutants that define the DRC, pf2 and pf3, assemble wild-type
levels of CSC components. However, only a small fraction of
the CSC is associated with CaM. Our working hypothesis is that
CaM association or dissociation with the CSC plays a role in
modulating dynein activity. To determine whether the CSC interacts with DRC components or specific subunits of dynein
arms will require the generation of additional reagents targeted
to these polypeptides.
Regardless of the mechanism for CSC modulation of dynein activity, our data indicate that specific dynein subforms are
affected (summarized in Fig. 6 E). Our antibodies either fail to
increase dynein activity or only modestly increase dynein activity in mutants lacking the outer dynein arms. In addition,

our antibodies do not increase dynein activity in double mutants
lacking the I1 inner dynein arm. In contrast, the CaM-IP2
antibodies fully restore dynein activity to mutants that lack the
I2 (fraction a, c, and d) inner arm heavy chains. Collectively,
these results indicate that the I1 inner dynein arm as well as the
outer dynein arms may be targets of regulation by the CSC.
In light of these results, it is interesting to note that in
recent structural experiments, Nicastro et al. (2006) have observed a structural linkage between the inner dynein arm I1 and
the outer dynein arms. In addition, work from several laboratories have indicated that inner dynein arm I1 is an important
regulatory target for modulating dynein-driven microtubule
sliding and that this modulation includes phosphorylation of
the I1 IC138 intermediate chain (Habermacher and Sale, 1996,
1997; King and Dutcher, 1997; Yang and Sale, 2000; Hendrickson
et al., 2004). Some I1-defective mutants can act as weak suppressors of paralysis for particular central apparatus–defective
mutants (Porter et al., 1992). Importantly, some I1-defective
mutants are deficient in their phototaxis response (King and
Dutcher, 1997; Okita et al., 2005). Our results indicate that the
overall phosphorylation state of IC138 does not change in either
radial spokeless or central pairless mutants upon addition of the
CaM-IP2 antibodies. Therefore, the increase in dynein activity we observe upon addition of our antibodies may involve a
mechanism that does not alter IC138 phosphorylation. Alternatively, addition of these antibodies may ultimately result in
changes in the phosphorylation of specific IC138 residues that
we cannot detect by Western blotting.
An additional challenge is to determine what role the
binding of Ca2+ to CaM plays in CSC-mediated changes in
dynein activity. We have previously shown that high calcium
buffer increases dynein activity in central pairless mutants but
not spokeless mutants and that CaM is a key calcium sensor
(Smith, 2002a). In the present study, we report the discovery of a
CaM-containing complex that exhibits calcium-sensitive CaM
binding. What we do not know is whether Ca2+-CaM release from
the CSC accounts for the increased dynein activity of central
pairless mutants in high calcium conditions. Interestingly, antibodies generated against one member of this complex increase
dynein activity in both central pairless and spokeless axonemes
in low calcium conditions. Is there a functional relationship between antibody binding to the CSC and high calcium conditions? Our observations that the CaM-IP2 antibody increases
dynein activity in mutants in which high calcium has no effect
(pf14) suggests that the antibody acts downstream of high calcium in a signal transduction pathway. A second possibility is
that high calcium affects additional axonemal targets that are
missing in these mutants, and these possibilities are not mutually exclusive. For example, CaM is a component of both the
central apparatus (Wargo et al., 2005) and radial spokes (Yang
et al., 2001), and several calcium-binding proteins, including
centrin, are associated with the dynein arms (for a complete list
of both known and putative calcium-binding proteins in flagella,
see Pazour et al., 2005).
To fully elucidate the mechanism by which the CSC participates in signal transduction pathways that modulate dynein
activity will require precisely localizing the CSC relative to the
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radial spokes and DRC, determining the stoichiometry of CSC
components relative to each other and the radial spokes, identifying additional CSC interactors (potentially including polypeptides comprising the DRC or dynein arms), and determining the
effects of calcium on the CSC modulation of dynein activity.

Materials and methods
C. reinhardtii strains
Strain A54-e18 (nit1-1, ac17, sr1, mt+), the wild-type strain for motility
and axoneme structure, was obtained from P. Lefebvre (University of
Minnesota, St Paul, MN). The central pair–defective strain pf18, the radial
spoke–defective strains pf17 and pf14, and the dynein-defective strains
pf2, pf3, ida1, ida4, and pf28 were obtained from the C. reinhardtii
Genetics Center (Duke University). The pf30pf28, pf14pf28, and pf14pf30
strains were obtained from W. Sale (Emory University, Atlanta, GA). Generation of the double mutants pf18pf28 and pf18ida1 have been previously described (Smith, 2002b). The double mutant pf18ida4 was selected
from nonparental ditype tetrads. All cells were grown in constant light in
Tris acetate phosphate media (Gorman and Levine, 1965).
Preparation of ﬂagella, ﬂagellar extracts, and sucrose gradients
Flagella were severed from cell bodies by the dibucaine method (Witman,
1986) and isolated by differential centrifugation in NaLow (10 mM Hepes,
pH 7.4, 5 mM MgSO4, 1 mM DTT, 0.5 mM EDTA, and 30 mM NaCl).
Axonemes were isolated by adding NP-40 (Calbiochem) to ﬂagella for a ﬁnal
concentration of 0.5% (wt/vol) to remove ﬂagellar membranes. Axonemes
were initially extracted in NaHigh (10 mM Hepes, pH 7.4, 5 mM MgSO4,
1 mM DTT, 0.5 mM EDTA, and 0.6 M NaCl) at a concentration of 6 mg/ml
on ice for 20 min. The axonemes were pelleted, resuspended in NaHigh,
and immediately pelleted again. The supernatant was discarded, and the
pellet was extracted with KI (10 mM Hepes, pH 7.4, 5 mM MgSO4, 1 mM
DTT, 0.5 mM EDTA, 30 mM NaCl, and 0.5 M KI) at a concentration of
12 mg/ml for 30 min on ice. This extract is referred to as the KI extract
or high salt extract. KI extracts were dialyzed against NaLow buffer and
clariﬁed by centrifugation at 12,000 relative centrifugal force for 10 min.
For some experiments, the clariﬁed extracts were loaded onto 5–20%
sucrose gradients and subjected to ultracentrifugation at 35,000 rpm for
16 h in an SW41Ti rotor (Beckman Coulter). 0.5-ml fractions were collected
from the bottom of the tube and prepared for SDS-PAGE.
Immunoprecipitation
Immunoprecipitation was performed according to Wargo et al. (2005)
with the following modiﬁcations. 150 μl KI axonemal extract was incubated with 40 μg of afﬁnity-puriﬁed anti-CaM or anti-IP2 antibody. After
four washes with TBST150 (150 mM NaCl, 50 mM Tris-HCl, and 0.5 mM
EDTA, pH 7.5), beads were resuspended in 90 μl TBST150 and 50 μl of
5× SDS-PAGE sample buffer. For experiments performed in high calcium,
a ﬁnal concentration of 1 mM CaCl2 was included in the TBST150 buffer,
and all washes were performed with TBST150 + 1 mM CaCl2. For immunoprecipitation performed in low calcium conditions followed by a ﬁnal high
calcium wash, the beads were washed as before with TBST150, and then
the beads were suspended in 100 μl TBST150 with 2 mM CaCl2. The beads
were rotated for 5 min at RT and brieﬂy spun, and the supernatant was
transferred to a new tube. 100 μl TBST150 was added to the remaining
beads, and all samples were prepared for SDS-PAGE gels. For immunoprecipitation using sucrose gradient fractions, 50–80 μg of antibody was
used with 1,200 μl of pooled sucrose gradient fractions. The sample was
mixed for 5–8 h and washed with four 1-ml vol of TBS-T150.
Mass spectrometry and sequence analysis
Gel bands were excised from Coomassie-stained gels. These bands were
analyzed by matrix-assisted laser desorption/ionization–time of ﬂight
mass spectrometry with postsource decay conducted at the University
of Massachusetts Medical School or liquid chromatography/liquid
chromatography–electrospray ionization mass spectrometry performed at
the Harvard Microchemistry and Proteomics Facility. Comparisons of peptide masses with translated genomic or EST sequences were made using
the BLAST algorithm at the National Center for Biotechnology Information
and the Chlamydomonas genome database (version 3.0; http://genome
.jgi-psf.org/Chlre3/Chlre3.home.html). Searches of the ﬂagellar proteome (Pazour et al., 2005) were performed using http://labs.umassmed
.edu/chlamyfp/index.php.
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The coding sequence for each polypeptide was conﬁrmed by RT-PCR.
RNA was isolated from wild-type C. reinhardtii cells before and after
pH shock–induced deﬂagellation according to Wilkerson et al. (1994).
PolyA enrichment was performed using the Oligotex mRNA kit (QIAGEN)
according to the manufacturer’s instructions. Reverse transcription was performed using either Superscript II or III (Invitrogen) according to the manufacturer’s instructions. Subsequent PCRs were performed using primers
based on the known or predicted coding regions as determined by EST,
EST contig, or mass spectrometry data.
Peptide and antibody production
The CaM peptide and corresponding antibodies as well as the anti-C1a32
antibodies were generated as described previously (Wargo et al., 2005).
For CaM-IP2, the ﬁrst 680 bp of the coding sequence was cloned into the
pET30 vector and transformed into BL21 (DE3) pLysS cells. Protein expression was induced by the addition of IPTG, and the expressed protein
was puriﬁed from bacterial cell lysates using a Ni2+-resin column according to the manufacturer’s protocol (Novagen). For CaM-IP3 antibodies, a
C-terminal peptide (CZTHAQDAVLEFARAHAAE) was synthesized and conjugated to keyhole limpet hemocyanin (Aves Labs, Inc.). For both CaM-IP2
and -IP3, polyclonal antibodies were generated in rabbits against the puriﬁed protein or peptide at Spring Valley Laboratories. Antibodies were
afﬁnity puriﬁed on Sulfolink columns (Pierce Chemical Co.) according to
the manufacturer’s protocol. Columns contained puriﬁed expressed protein
(CaM-IP2) or puriﬁed peptide (CaM-IP3).
Gel electrophoresis, Western blots, and silver-stained gels
For immunoblots, equivalent loads of ﬂagella (8 mg/ml), axonemes, extracts, and/or extracted axonemes were subjected to SDS-PAGE using 7%
polyacrylamide gels. Gels were transferred to polyvinylidene diﬂuoride
(Immobilon P; Millipore). CaM Western blots were performed as previously described (Wargo et al., 2005). For CaM-IP2 and -IP3 Western analyses, 7% polyacrylamide gels were subject to SDS-PAGE and transferred
for 1 h to polyvinylidene diﬂuoride (Immobilon P; Millipore). Membranes
were blocked for 1 h in 2% BSA (regular fraction V; A-7906; SigmaAldrich) in TBST (0.1% Tween and TBS, pH 7.5). For primary antibody
incubations, afﬁnity-puriﬁed anti–CaM-IP2 or anti–CaM-IP3 antibodies
were diluted 1:100 or 1:5,000, respectively, and anti-RSP2 or anti-RSP3
antibodies (provided by D. Diener, Yale University, New Haven, CT) were
diluted 1:5,000 in TBST. Primary antibody incubations were conducted for
2 h at RT or overnight at 4°C. Membranes were washed three times for
5 min with TBST, incubated with anti–rabbit HRP secondary antibodies
(GE Healthcare), and diluted 1:30,000 in TBST. After four 5-min washes
with TBST, the ECL Plus Western Blotting kit (GE Healthcare) was used for
chemiluminescent detection. Gels were silver stained according to the
methods described in Wargo et al. (2005).
For anti-IC138 Western blots, axonemes isolated from wild type,
pf14, and pf18 were resuspended at 1 mg/ml in pCa8 or pCa4 buffer
containing 1 mM ATP. For some samples, 50 μg of axonemes were treated
with 4 μg of afﬁnity pure anti–CaM-IP2 or 4 μg of afﬁnity pure anti–C1a32 antibodies (Wargo et al., 2005). For samples that were treated with
calf intestine alkaline phosphatase (Roche), the axonemes were incubated
with 0.75 U of calf intestine alkaline phosphatase for 30 min at RT. 10 μg
axonemal proteins were resolved on a 5% polyacrylamide gel and transferred to nitrocellulose. Blots were incubated with anti-IC138 (1:10,000 in
TBST) overnight at 4°C. After washing, blots were incubated for 45 min
with anti–rabbit HRP in TBST, washed, and incubated with ECL Plus for
detection. The IC138 antibodies were provided by W. Sale.
Blot overlay
RSP3-GST (provided by W. Sale) was expressed and puriﬁed on a GSTresin column (Novagen) according to the manufacturer’s protocol. The N
terminus of CaM-IP2 was expressed and puriﬁed as described in Peptide
and antibody production. For CaM-IP3, DNA sequence encoding the
C-terminal 220 amino acids was cloned into pET30 and transformed into
BL21 (DE3) pLysS cells. For CaM-IP4, 1.8 kb of DNA sequence encoding
amino acids 1–580 was cloned into the pET30 vector. Expression was
induced with IPTG, and proteins were puriﬁed from bacterial cell lysates
using a Ni2+-resin column (Novagen). For SDS-PAGE, 15 μg CaM-IP2
(37 kD), 15 μg CaM-IP3 (32 kD), 15 μg CaM-IP4 (62 kD), and 25 μg
RSP3-GST (110 kD) were resolved on a 12% polyacrylamide gel and transferred for 40 min to nitrocellulose membrane. Membranes were blocked
overnight at 4°C in 5% milk/TBST (0.1% Tween) and were incubated with
40 μg/ml RSP3-GST in 1% BSA/TBST for 2 h at RT. After three 5-min TBST
washes, membranes were incubated with anti-RSP3 (1:5,000) in TBST for
1 h and with secondary antibody (anti–rabbit HRP; GE Healthcare) diluted

1:30,000 in TBST for 30 min. The ECL Plus Western Blotting kit (GE Healthcare) was used for detection.
Microtubule sliding
Flagella were severed from cell bodies by the dibucaine method (Witman,
1986) and isolated by differential centrifugation in buffer A (10 mM
Hepes, pH 7.4, 5 mM MgSO4, 1 mM DTT, 0.5 mM EDTA, and 50 mM
potassium acetate). Axonemes were isolated by adding NP-40 (Calbiochem)
to ﬂagella for a ﬁnal concentration of 0.5% (wt/vol) to remove ﬂagellar
membranes. Measurement of sliding velocity between doublet microtubules
was based on the methods of Okagaki and Kamiya (1986). Microtubule
sliding was initiated with buffer A containing 1 mM ATP and 2 μg/ml type
VIII protease (Sigma-Aldrich) and was recorded as described previously
(Smith, 2002a). All data are presented as mean ± SEM. The t test was
used to determine the signiﬁcance of differences between means. For some
experiments, axonemes were incubated with afﬁnity-puriﬁed anti–CaM-IP2
antibodies for 15 min at room temperature (22°C) before the induction of
sliding. Antibody concentrations are noted on corresponding ﬁgures and
are estimates based on the conversion factor of IgG = 150,000 g/mol.
Online supplemental material
Fig. S1 shows an amino acid sequence comparison of CaM-IP2 and
human AAT-1. Fig. S2 shows Northern blots comparing transcript levels of
CaM-IP2 and RSP3 before and after deﬂagellation. Fig. S3 shows Western
blots of sucrose gradient fractions and immunoprecipitation experiments of
corresponding pooled fractions. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200703107/DC1.
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